[Influenza vaccines adjuvants--contemporary state]

Area of Science:

• Immunology and Vaccinology
• Virology
• Pharmaceutical Sciences

Context:

• Influenza viruses, including avian and seasonal strains, pose significant global health threats.
• Adjuvants are critical components for improving vaccine immunogenicity and effectiveness.
• Existing influenza vaccines require optimization for broader and more potent immune responses.

Purpose:

• To review the development and study of adjuvants for influenza vaccines.
• To analyze the requirements and classifications of potential adjuvants.
• To evaluate the clinical trial data of adjuvanted vaccines against avian influenza.

Summary:

• This study presents data on the development and investigation of adjuvants for influenza vaccines targeting avian and seasonal influenza.
• Key adjuvant groups discussed include aluminum salts, squalene derivatives, polyglycosides, and immunomodulators, alongside experimental options.
• Analysis of clinical trials for avian influenza adjuvanted vaccines indicates a positive outlook.

Impact:

• Adjuvanted influenza vaccines demonstrate good potential for improved protection against both avian and seasonal influenza.
• This research supports the advancement of novel adjuvant technologies for next-generation influenza vaccines.
• Findings may guide future vaccine development strategies to enhance pandemic preparedness and seasonal disease control.